Mitomycin A

• CAT Number: R007342
• CAS Number: 4055-39-4
• Molecular Formula: C16H19N3O6
• Molecular Weight: 349.343
• Purity: ≥95%
• Synonyms: (1aS,8S,8aR,8bS)-8-[[(Aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-6,8a-dimethoxy-5-methylazirino[2’,3’:3,4]pyrrolo[1,2-a]indole-4,7-dione
• Target: Immunology/Inflammation
• Storage: -20°C
• InChI: InChI=1S/C16H19N3O6/c1-6-11(20)10-9(12(21)13(6)23-2)7(5-25-15(17)22)16(24-3)14-8(18-14)4-19(10)16/h7-8,14,18H,4-5H2,1-3H3,(H2,17,22)/t7-,8+,14+,16-/m1/s1
• InChIKey: HYFMSAFINFJTFH-NGSRAFSJSA-N
• SMILES: CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)OC

Mitomycin A is a naturally occurring antibiotic and anticancer agent used in pharmaceutical and biochemical research. Known for its DNA cross-linking properties, it is essential for studying the mechanisms of action, cytotoxicity, and therapeutic potential of antineoplastic agents. This compound aids in developing new treatments for various cancers and understanding the molecular basis of its anticancer effects. Researchers rely on Mitomycin A for precise and reliable results in advanced oncology research, drug development, and medicinal chemistry, contributing significantly to innovations in cancer therapy.